Benchmark Raises Lucid Price Target to $7

Analyst: Mickey Legg 1 min read Reproduced verbatim Published as The Benchmark Company, now part of StoneX
Rating
Buy
Target
$7
from $5 (+40%)
Outcome
Missed
within 12 months

StoneX’s latest target on Lucid is now $30 (Feb 19, 2026); the median of 6 firms is $4.50. StoneX has reached 71% of its year-old targets (24 scored).

StoneX and Lucid logos

What the analyst said

Benchmark analyst Mickey Legg raised the price target on Lucid Group Inc. (NASDAQ: LCID) to $7.00 (from $5.00) while maintaining a Buy rating.

“Lucid Announces Strategic Partnership with Uber and Nuro, Inc. Lucid has entered into a landmark partnership with Uber and autonomous vehicle developer Nuro, Inc. to deploy 20,000 Gravity SUVs equipped with the Nuro Driver over six years.

The first vehicles are expected to launch next year. As part of the agreement Uber’s subsidiary, SMB Holding Corp., will make a $300 million private placement investment in Lucid, priced at the 30-day VWAP and subject to an 18-month lock-up.

The investment is expected to close and price in Q3. Additionally, Lucid announced a proposed 1-for-10 reverse stock split, with shareholder voting scheduled for 8/18. We view the partnership as a clear strategic win, bringing in capital and two world-class partners while expanding Lucid’s reach into autonomous ride-hailing.

The stock is up over 40% today, and as such we are raising our price target to $7.00 from $5.00. We reiterate our Buy rating and recommend buying ahead of Lucid’s 2Q25 earnings on 8/5, where we expect continued positive momentum.”

Price Target note: Lucid completed a 1-for-10 reverse stock split on September 2, 2025. The price targets in this note predate the split and are quoted in pre-split share terms; multiply them by 10 to compare with the share price after the split.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LCID trades at $3.26. The 6 analysts who set a target in the last 3 months range from $3 to $9, with a median of $4.50. This $7 target is 56% above the median.

Since the note LCID has moved −86% (from $22.90). The 12-month window closed on July 17, 2026.

Track record

This call✗ Not reached within 12 months: a year after the note LCID closed at $7.36, 89% below the $70 target, and it moved the other way. Prices are split-adjusted. Same target as this firm’s July 17, 2025 note, so it is scored there.

Firm track recordStoneX: 71% of its 24 targets at least a year old were reached within 12 months (#18 of 26 firms); on Lucid, 0 of 3. Accuracy ranking →

StoneX on Lucid

StoneX price targets on Lucid

8 calls from February 12, 2025 to November 13, 2025. The target went from $5 to $3 (−40%). The rating stayed Buy.

StoneX target
  1. November 13, 2025Target cut from $7 (−57%)Buy$3
  2. August 6, 2025Kept the $7 targetBuy$7
  3. July 17, 2025Kept the $7 targetBuy$7
  4. July 17, 2025 This noteTarget raised from $5 (+40%)Buy$7
  5. July 10, 2025Kept the $5 targetBuy$5
  6. April 4, 2025Kept the $5 targetBuy$5
  7. March 7, 2025Kept the $5 targetBuy$5
  8. February 12, 2025Earliest call shownBuy$5

Targets are adjusted for the 1-for-10 reverse split on Sep 2, 2025, so every call is in the same share terms as this note.

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.